DK523276A - Fremgangsmade til fremstilling af n-acylderivater af thienamycin - Google Patents

Fremgangsmade til fremstilling af n-acylderivater af thienamycin

Info

Publication number
DK523276A
DK523276A DK523276A DK523276A DK523276A DK 523276 A DK523276 A DK 523276A DK 523276 A DK523276 A DK 523276A DK 523276 A DK523276 A DK 523276A DK 523276 A DK523276 A DK 523276A
Authority
DK
Denmark
Prior art keywords
thienamycin
preparing
procedure
acyl derivatives
acyl
Prior art date
Application number
DK523276A
Other languages
English (en)
Inventor
L Barash
B G Christensen
J Hannah
W J Leanza
D H M Shih
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK523276A publication Critical patent/DK523276A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK523276A 1975-11-21 1976-11-19 Fremgangsmade til fremstilling af n-acylderivater af thienamycin DK523276A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63429175A 1975-11-21 1975-11-21

Publications (1)

Publication Number Publication Date
DK523276A true DK523276A (da) 1977-05-22

Family

ID=24543192

Family Applications (1)

Application Number Title Priority Date Filing Date
DK523276A DK523276A (da) 1975-11-21 1976-11-19 Fremgangsmade til fremstilling af n-acylderivater af thienamycin

Country Status (8)

Country Link
JP (1) JPS5277083A (da)
CH (1) CH632509A5 (da)
DE (1) DE2652675A1 (da)
DK (1) DK523276A (da)
FR (1) FR2332016A1 (da)
GB (1) GB1570986A (da)
NL (1) NL189298C (da)
SE (1) SE427840B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2966187D1 (en) * 1978-08-23 1983-10-27 Beecham Group Plc Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
DK456580A (da) * 1979-10-29 1981-06-04 Beecham Group Ltd Fremgangsmaade til fremstilling af bicycliske beta-lactamringholdige forbindelser
EP0044142A1 (en) * 1980-07-03 1982-01-20 Beecham Group Plc Process for the preparation of beta-lactam antibiotics
US10695322B2 (en) 2016-01-29 2020-06-30 The Johns Hopkins University Inhibitors of bacterial growth

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348984A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Antibiotics and processes for their production

Also Published As

Publication number Publication date
FR2332016A1 (fr) 1977-06-17
SE7612960L (sv) 1977-05-22
DE2652675C2 (da) 1990-02-01
CH632509A5 (en) 1982-10-15
NL7612940A (nl) 1977-05-24
NL189298C (nl) 1993-03-01
NL189298B (nl) 1992-10-01
JPS5277083A (en) 1977-06-29
SE427840B (sv) 1983-05-09
GB1570986A (en) 1980-07-09
JPS61346B2 (da) 1986-01-08
DE2652675A1 (de) 1977-06-02
FR2332016B1 (da) 1978-11-10

Similar Documents

Publication Publication Date Title
DK494876A (da) Fremgangsmade til fremstilling af piperidinderivater
DK567376A (da) Fremgangsmade til fremstilling af quinazolonderivater
DK562376A (da) Fremgangsmade til fremstilling af ergolinderivater
DK170678A (da) Fremgangsmaade til fremstilling af n-alkyl-n-acyl-derivater af thienamycin
DK462376A (da) Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater
DK479976A (da) Fremgangsmade til fremstilling af antibiotiske cephalosporinderivater
DK545076A (da) Fremgangsmade til fremstilling af imidazolderivater
DK272676A (da) Fremgangsmade til fremstilling af cephalosporinforbindelser
DK523676A (da) Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin
DK149194C (da) Fremgangs-maade til fremstilling af (r)-n-phenylalaninderivater
DK528976A (da) Fremgangsmade til fremstilling af indazolderivater
DK324176A (da) Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK298476A (da) Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK343275A (da) Fremgangsmade til fremstilling af cephalosporinderivater
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK209076A (da) Fremgangsmade til fremstilling af phenylpiperidinderivater
DK565676A (da) Fremgangsmade til fremstilling af klavamderivater
DK296175A (da) Fremgangsmade til fremstilling af cephalosporinderivater
DK523276A (da) Fremgangsmade til fremstilling af n-acylderivater af thienamycin
DK523576A (da) Fremgangsmade til fremstilling af substituerede n-methylen-derivater af thienamycin
DK551076A (da) Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK343976A (da) Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
DK435375A (da) Fremgangsmade til fremstilling af cephalosporinderivater
DK251176A (da) Fremgangsmade til fremstilling af cyklopropanolderivater
DK253676A (da) Fremgangsmade til fremstilling af cycloheptathiopenderivater

Legal Events

Date Code Title Description
ATS Application withdrawn